Clinical Trial Update: SMART Trial: Cognitive Sparing Brain Radiotherapy for Multiple Brain Metastases [Phase 2]

View source ↗

Summary

The SMART trial is evaluating cognitive-sparing brain radiotherapy for patients with multiple brain metastases in solid tumors. The Phase 2 study is currently n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Brain Metastases From Solid Tumors | Phase 2 | Status: NOT_YET_RECRUITING